血清EPOR,IGF-1,MBP在新生儿脑损伤中的研究进展

来源 :疾病监测与控制 | 被引量 : 0次 | 上传用户:kkkhorse
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
新生儿脑损伤因其病因不同,早期判断有一定困难。寻求一种或几种新生儿脑损伤早期诊断敏感特异的检测指标,成为儿科领域亟待解决的问题。在发生新生儿脑损伤时,促红细胞生成素受体(EPOR),胰岛素样生长因子-1(IGF-1),髓鞘碱性蛋白(MBP)的检测,对新生儿脑损伤早期诊断及判断预后具有一定指导意义。 Neonatal brain damage due to their different etiologies, early judgment has some difficulties. It is an urgent problem to be solved in the field of pediatrics to seek sensitive and specific detection indexes for early diagnosis of one or more kinds of neonatal brain injury. In neonatal brain injury, the detection of erythropoietin receptor (EPOR), insulin-like growth factor-1 (IGF-1) and myelin basic protein (MBP), early diagnosis and judgment of neonatal brain injury Prognosis has some guiding significance.
其他文献